Finance

Beta
Lists
082850:KOSDAQ
Wooree Bio Co Ltd
₩1,403.00
-1.13%
(-16.00) 1D
Jun 15, 3:30:27 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 082850...
Open
₩1,419
High
₩1,473
Low
₩1,395
Mkt. cap
67.98B
Avg. vol.
292.97K
Volume
111.07K
Dividend
1.43%
Quarterly dividend
₩5
Ex-dividend date
Dec 29, 2025
52-wk high
₩2,675
52-wk low
₩1,331
EPS
-₩152
Shares outstanding
48.46M
No. of employees
89
Open
₩1,419
High
₩1,473
Low
₩1,395
Mkt. cap
67.98B
Avg. vol.
292.97K
Volume
111.07K
Dividend
1.43%
Quarterly dividend
₩5
Ex-dividend date
Dec 29, 2025
52-wk high
₩2,675
52-wk low
₩1,331
EPS
-₩152
Shares outstanding
48.46M
No. of employees
89
News stories
From sources across the web
About Wooree Bio Co Ltd
CEOPark Kil-Soo
Employees89
Founded2000
Headquarters-
SectorSemiconductor
Websitewooreebio.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
231.01B
263.90B
250.75B
269.20B
Cost of goods sold
207.83B
237.91B
229.54B
245.82B
Cost of revenue
207.83B
237.91B
229.54B
245.82B
Research and development expenses
2.72B
2.44B
2.94B
2.73B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.74B
18.32B
17.16B
23.18B
Operating expense
25.79B
23.37B
21.04B
27.69B
Total operating expenses
233.62B
261.28B
250.58B
273.51B
Operating income
-2.61B
2.62B
168.05M
-4.32B
Other non operating income
-1.91B
1.25B
-788.82M
1.71B
EBT including unusual items
-10.24B
5.59B
-1.51B
1.35B
EBT excluding unusual items
-8.54B
5.07B
108.51M
1.37B
Income tax expense
965.77K
2.88B
594.12M
994.41M
Effective tax rate
-0.01%
51.57%
-39.27%
73.92%
Other operating expenses
342.86M
448.77M
287.12M
470.97M
Net income
-10.35B
2.48B
-977.14M
2.18B
Net profit margin
-4.48%
0.94%
-0.39%
0.81%
Earnings per share
-
-
-
-
Interest and investment income
1.00B
901.88M
860.54M
673.82M
Interest expense
-1.61B
-1.23B
-1.41B
-1.35B
Net interest expenses
-610.64M
-331.83M
-549.25M
-674.42M
Depreciation and amortization charges
1.15B
1.16B
1.23B
1.11B
EBITDA
4.30B
9.41B
7.24B
2.42B
Gain or loss from assets sale
22.81M
-509.48M
669.39M
21.18M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer